Skip to main content
. 2020 Jan 9;15(7):1266–1273. doi: 10.4103/1673-5374.272616

Figure 3.

Figure 3

Comparison of the degree of disability using modified Rankin Scale scores of acute cerebral infarction patients between the cattle encephalon glycoside and ignotin (CEGI) subgroup and the placebo subgroup on day 90.

(A, B) Degree of disability in the mild (A) and moderate (B) stroke subgroups in the full analysis set (FAS) (CEGI group, n = 229; placebo group, n = 78) and the per-protocol set (PPS) (CEGI group, n = 218; placebo group, n = 73). The rank-sum test was used to compare the rates of disability between the CEGI and placebo subgroups. *P < 0.05.